BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6696762)

  • 1. A new class of antihypertensive neutral lipid: 1-alkyl-2-acetyl-sn-glycerols, a precursor of platelet activating factor.
    Blank ML; Cress EA; Snyder F
    Biochem Biophys Res Commun; 1984 Jan; 118(1):344-50. PubMed ID: 6696762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion of 1-alkyl-2-acetyl-sn-glycerols to platelet activating factor and related phospholipids by rabbit platelets.
    Blank ML; Lee TC; Cress EA; Malone B; Fitzgerald V; Snyder F
    Biochem Biophys Res Commun; 1984 Oct; 124(1):156-63. PubMed ID: 6497876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.
    Blank ML; Spector AA; Kaduce TL; Lee TC; Snyder F
    Biochim Biophys Acta; 1986 May; 876(3):373-8. PubMed ID: 3707974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor and a hypotensive lipid) by cholinephosphotransferase in various rat tissues.
    Renooij W; Snyder F
    Biochim Biophys Acta; 1981 Feb; 663(2):545-56. PubMed ID: 6260215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the synthesis of platelet-activating factor and its inactive storage precursor (1-alkyl-2-acyl-sn-glycero-3-phosphocholine) from 1-alkyl-2-acetyl-sn-glycerol by rabbit platelets.
    Lee TC; Malone B; Blank ML; Fitzgerald V; Snyder F
    J Biol Chem; 1990 Jun; 265(16):9181-7. PubMed ID: 2160964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural features of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) required for hypotensive and platelet serotonin responses.
    Blank ML; Cress EA; Lee TC; Malone B; Surles JR; Piantadosi C; Hajdu J; Snyder F
    Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):3-20. PubMed ID: 7146619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 1-O-alkyl-, 1-O-alk-1'-enyl-, and 1-O-acyl-2-acetyl-sn-glycero-3-phosphoethanolamines and -3-phosphocholines as agonists of the platelet-activating factor family.
    O'Flaherty JT; Tessner T; Greene D; Redman JR; Wykle RL
    Biochim Biophys Acta; 1994 Jan; 1210(2):209-16. PubMed ID: 8280772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of 1-alkyl-2-acetyl-sn-glycerols via the de novo biosynthetic pathway for platelet-activating factor. Characterization of 1-alkyl-2-acetyl-sn-glycero-3-phosphate phosphohydrolase in rat spleens.
    Lee TC; Malone B; Snyder F
    J Biol Chem; 1988 Feb; 263(4):1755-60. PubMed ID: 2828351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells.
    Chao W; Siafaka-Kapadai A; Hanahan DJ; Olson MS
    Biochem J; 1989 Jul; 261(1):77-81. PubMed ID: 2775221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the synthesis of platelet-activating factor via acetylation of 1-alkyl-sn-glycero-3-phosphocholine. Formation of structural isomer of PAF in the presence of bases.
    Chupin VV; Ostapenko OV; Klykov VN; Anikin MV; Serebrennikova GA
    Chem Phys Lipids; 1996 Jun; 81(1):35-43. PubMed ID: 9471401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adrenergic system and the cardiovascular effects of platelet activating factor (1-0-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine) in SHR and WKY rats.
    Zukowska-Grojec Z; Blank ML; Snyder F; Feuerstein G
    Clin Exp Hypertens A; 1985; 7(7):1015-31. PubMed ID: 2994912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facile synthesis of platelet-activating factor and racemic analogues containing unsaturation in the sn-1-alkyl chain.
    Surles JR; Wykle RL; O'Flaherty JT; Salzer WL; Thomas MJ; Snyder F; Piantadosi C
    J Med Chem; 1985 Jan; 28(1):73-8. PubMed ID: 4038418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biochemical studies of analogs of platelet-activating factor bearing a methyl group at C2 of the glycerol backbone.
    Bittman R; Witzke NM; Lee TC; Blank ML; Snyder F
    J Lipid Res; 1987 Jun; 28(6):733-8. PubMed ID: 3611974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential responsiveness of human neutrophils to the autocrine actions of 1-O-alkyl-homologs and 1-acyl analogs of platelet-activating factor.
    Pinckard RN; Showell HJ; Castillo R; Lear C; Breslow R; McManus LM; Woodard DS; Ludwig JC
    J Immunol; 1992 Jun; 148(11):3528-35. PubMed ID: 1316919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors that influence the proportions of platelet-activating factor and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine synthesized by the mast cell.
    Triggiani M; Fonteh AN; Chilton FH
    Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):497-503. PubMed ID: 1530582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
    Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J
    Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac output and peripheral vascular resistance during intravenous infusion of 1-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine in conscious normotensive and spontaneously hypertensive rats.
    Hubbard JW; Cox RH; Lawler JE; Blank ML; Snyder F
    Res Commun Chem Pathol Pharmacol; 1985 Sep; 49(3):459-62. PubMed ID: 4059660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic synthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine, a hypotensive and platelet-aggregating lipid.
    Wykle RL; Malone B; Snyder F
    J Biol Chem; 1980 Nov; 255(21):10256-60. PubMed ID: 7430122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histamine release from human leukocytes after treatment with 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) and its structural analogs].
    Orlov SM; Kulikov VI; Pol'ner AA; Bergel'son LD
    Biokhimiia; 1985 Apr; 50(4):680-5. PubMed ID: 2408682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Formation of a structural isomer of platelet activating factor during acetylation of 1-alkyl-sn-glycero-3-phosphocholine].
    Chupin VV; Ostapenko OV; Klykov VN; Anikin MV; Serebrennikova GA
    Bioorg Khim; 1993 Nov; 19(11):1111-21. PubMed ID: 8285924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.